Lupin Limited
NSE:LUPIN.NS
Overview | Financials
Company Name | Lupin Limited |
Symbol | LUPIN.NS |
Currency | INR |
Price | 2,104.6 |
Market Cap | 960,107,997,000 |
Dividend Yield | 0.24% |
52-week-range | 1,153.55 - 2,312 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Vinita D. Gupta |
Website | https://www.lupin.com |
An error occurred while fetching data.
About Lupin Limited
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD